Search

everythinglearnresearchcommunity

for

Search:↓

Simvastatin may help manage symptoms in women with non-classic congenital adrenal hyperplasia by lowering cholesterol and certain hormone levels.

Irregular menstrual cycles in teenagers are linked to a higher risk of polycystic ovary syndrome and metabolic syndrome.

Anovulatory PCOS patients are younger with longer cycles and higher blood pressure and hormone levels.

Hormonal imbalances, not insulin resistance or dyslipidemia, may be more important in causing acne in women over 25.

Women with acne and PCOS should be checked for insulin resistance and related symptoms.

Agaricus subrufescens improves ovarian function and biochemical health in rats with PCOS.

High androgen levels in young women with PCOS are linked to higher blood pressure.

Different types of polycystic ovary syndrome (PCOS) have varying severity, with Type I being the most severe and common.

Treating sleep apnea in young obese women with PCOS can improve heart health and insulin sensitivity.

Weight loss and metformin don't significantly change vaspin levels in women with PCOS.

High afamin levels are linked to metabolic syndrome and may predict its development in women with insulin resistance.

Chromium picolinate was better tolerated than metformin for PCOS with fewer side effects.

The conclusion is that a more comprehensive and precise approach is needed for diagnosing PCOS to address its broader health risks.

Women with PCOS often have more belly fat and higher insulin levels, but belly fat isn't the only cause of their insulin resistance.

Higher levels of unbound testosterone are linked to increased insulin resistance, especially in women with polycystic ovary syndrome.

Too much male hormone is the main cause of Polycystic Ovary Syndrome.

Myo-inositol may be more effective than metformin for inducing ovulation in women with PCOS.

Adults with polycystic ovary syndrome are much more likely to have obstructive sleep apnea.

Women with PCOS are more likely to have sleep apnea, mainly if they are obese.

High androgen levels in Chinese women with PCOS are linked to a higher risk of diabetes and obesity.

The review suggests thorough evaluation and genetic testing for proper diagnosis and treatment of Chrousos syndrome.

Obese women with PCOS are more likely to have fatty liver disease.

Women with PCOS are more likely to have insulin resistance and obesity, especially those with the most severe type I PCOS.

Cyproterone acetate treatment is safe and causes mild feminization, which increases with added estrogen.

More PDCD4 is linked to obesity, insulin problems, and cell death in ovaries for those with polycystic ovary syndrome.

Young women with PCOS have a higher risk of high blood pressure and metabolic syndrome, but these risks may decrease after age 40.

Researchers found potential urine markers for polycystic ovary syndrome, including testosterone-glucuronide and 11α-hydroxyprogesterone, which may help diagnose the condition.

Most patients improved with oral contraceptives, but some needed additional treatment.

A combined drug and laser treatment improved hirsutism in a PCOS patient, also enhancing her heart health and requiring regular liver and kidney checks.

The research suggests that the ZP4 gene is linked to egg development in women with PCOS but requires more study to understand its role in infertility.